ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS - Rech, Jürgen; Kleyer, Arnd; Ostergaard, M.; Hagen, Melanie; Valor, L.; Tascilar, Koray; Krönke, Gerhard; Schönau, Verena; Kleinert, Stefan; Baraliakos, X.; Braun, J.; Fleck, M.; et al. (ANNALS OF THE RHEUMATIC DISEASES, 2022)
CRIS-Team WoS Importer:2022-11-04